The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarkers to predict the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer with actionable genetic alterations.
 
Soojin Jun
No Relationships to Disclose
 
Hyun Ae Jung
Consulting or Advisory Role - AIMEDBIO; Guardant Health; Yuhan
Research Funding - Yuhan
 
Myung-Ju Ahn
Honoraria - Amgen; AstraZeneca; Lilly; Merck Serono; MSD; TAKEDA; YUHAN
Consulting or Advisory Role - Alpha pharmaceutical; Amgen; AstraZeneca; Lilly; Merck Serono; MSD; Pfizer; TAKEDA; YUHAN
Research Funding - YUHAN
 
JinSeok Ahn
Honoraria - Amgen; AstraZeneca; Bayer; BC World Pharmaceutical; Boehringer Ingelheim; Hanmi; JW Pharmaceutical; Kyowa Kirin; Lilly; Menarini; Novartis; Pfizer; Roche; Takeda; Yuhan
Consulting or Advisory Role - Bayer; Guardant Health; ImmuneOncia; Pharmbio Korea; Vifor Pharma; Yooyoung Pharmaceutical Co. Ltd; Yuhan
 
Se-Hoon Lee
No Relationships to Disclose
 
Jong Mu Sun
No Relationships to Disclose
 
Sehhoon Park
No Relationships to Disclose
 
Juhee Cho
No Relationships to Disclose